Previous Article | Next Article 
Mol Cell Biol. 1990 December; 10(12): 6426-6435
The SCL gene is formed from a transcriptionally complex locus.
P D Aplan,
C G Begley,
V Bertness,
M Nussmeier,
A Ezquerra,
J Coligan and
I R Kirsch
Navy Medical Branch, National Cancer Institute, Bethesda, Maryland 20814.
ABSTRACT
We describe the structural organization of the human SCL gene, a helix-loop-helix family member which we believe plays a fundamental role in hematopoietic differentiation. The SCL locus is composed of eight exons distributed over 16 kb. SCL shows a pattern of expression quite restricted to early hematopoietic tissues, although in malignant states expression of the gene may be somewhat extended into later developmental stages. A detailed analysis of the transcript(s) arising from the SCL locus revealed that (i) the 5' noncoding portion of the SCL transcript, which resides within a CpG island, has a complex pattern of alternative exon utilization as well as two distinct transcription initiation sites; (ii) the 5' portions of the SCL transcript contain features that suggest a possible regulatory role for these segments; (iii) the pattern of utilization of the 5' exons is cell lineage dependent; and (iv) all of the currently studied chromosomal aberrations that affect the SCL locus either structurally or functionally eliminate the normal 5' transcription initiation sites. These data suggest that the SCL gene, and specifically its 5' region, may be a target for regulatory interactions during early hematopoietic development.
Mol Cell Biol. 1990 December; 10(12): 6426-6435
This article has been cited by other articles:
-
Bockamp, E., Antunes, C., Maringer, M., Heck, R., Presser, K., Beilke, S., Ohngemach, S., Alt, R., Cross, M., Sprengel, R., Hartwig, U., Kaina, B., Schmitt, S., Eshkind, L.
(2006). Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells. Blood
108: 1533-1541
[Abstract]
[Full Text]
-
Lazrak, M., Deleuze, V., Noel, D., Haouzi, D., Chalhoub, E., Dohet, C., Robbins, I., Mathieu, D.
(2004). The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis. J. Cell Sci.
117: 1161-1171
[Abstract]
[Full Text]
-
Calkhoven, C. F., Muller, C., Martin, R., Krosl, G., Hoang, T., Leutz, A.
(2003). Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes Dev.
17: 959-964
[Abstract]
[Full Text]
-
Tang, T., Arbiser, J. L., Brandt, S. J.
(2002). Phosphorylation by Mitogen-activated Protein Kinase Mediates the Hypoxia-induced Turnover of the TAL1/SCL Transcription Factor in Endothelial Cells. J. Biol. Chem.
277: 18365-18372
[Abstract]
[Full Text]
-
Sinclair, A. M., Bench, A. J., Bloor, A. J. C., Li, J., Gottgens, B., Stanley, M. L., Miller, J., Piltz, S., Hunter, S., Nacheva, E. P., Sanchez, M.-J., Green, A. R.
(2002). Rescue of the lethal scl-/- phenotype by the human SCL locus. Blood
99: 3931-3938
[Abstract]
[Full Text]
-
Mead, P. E., Deconinck, A. E., Huber, T. L., Orkin, S. H., Zon, L. I.
(2001). Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins. Development
128: 2301-2308
[Abstract]
[Full Text]
-
Courtes, C., Lecointe, N., Le Cam, L., Baudoin, F., Sardet, C., Mathieu-Mahul, D.
(2000). Erythroid-specific Inhibition of the tal-1 Intragenic Promoter Is Due to Binding of a Repressor to a Novel Silencer. J. Biol. Chem.
275: 949-958
[Abstract]
[Full Text]
-
Chervinsky, D. S., Zhao, X.-F., Lam, D. H., Ellsworth, M., Gross, K. W., Aplan, P. D.
(1999). Disordered T-Cell Development and T-Cell Malignancies in SCL LMO1 Double-Transgenic Mice: Parallels with E2A-Deficient Mice. Mol. Cell. Biol.
19: 5025-5035
[Abstract]
[Full Text]
-
Begley, C. G., Green, A. R.
(1999). The SCL Gene: From Case Report to Critical Hematopoietic Regulator. Blood
93: 2760-2770
[Full Text]
-
Zhao, X.-F., Aplan, P. D.
(1999). The Hematopoietic Transcription Factor SCL Binds the p44 Subunit of TFIIH. J. Biol. Chem.
274: 1388-1393
[Abstract]
[Full Text]
-
Sanchez, M, Gottgens, B, Sinclair, A., Stanley, M, Begley, C., Hunter, S, Green, A.
(1999). An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development
126: 3891-3904
[Abstract]
-
Minegishi, N., Ohta, J., Suwabe, N., Nakauchi, H., Ishihara, H., Hayashi, N., Yamamoto, M.
(1998). Alternative Promoters Regulate Transcription of the Mouse GATA-2 Gene. J. Biol. Chem.
273: 3625-3634
[Abstract]
[Full Text]
-
Goldfarb, A. N., Lewandowska, K., Pennell, C. A.
(1998). Identification of a Highly Conserved Module in E Proteins Required for in Vivo Helix-loop-helix Dimerization. J. Biol. Chem.
273: 2866-2873
[Abstract]
[Full Text]
-
Mead, P., Kelley, C., Hahn, P., Piedad, O, Zon, L.
(1998). SCL specifies hematopoietic mesoderm in Xenopus embryos. Development
125: 2611-2620
[Abstract]
-
Zhang, M.-Y., Clawson, G. A., Olivieri, N. F., Bell, L. L., Begley, C. G., Miller, B. A.
(1997). Expression of SCL Is Normal in Transfusion-Dependent Diamond-Blackfan Anemia But Other bHLH Proteins Are Deficient. Blood
90: 2068-2074
[Abstract]
[Full Text]
-
Bockamp, E.-O., McLaughlin, F., Gottgens, B., Murrell, A. M., Elefanty, A. G., Green, A. R.
(1997). Distinct Mechanisms Direct SCL/tal-1 Expression in Erythroid Cells and CD34 Positive Primitive Myeloid Cells. J. Biol. Chem.
272: 8781-8790
[Abstract]
[Full Text]
-
Wu, Y.-j., Fraizer, G. C., Saunders, G. F.
(1995). GATA-1 Transactivates the WT1 Hematopoietic Specific Enhancer. J. Biol. Chem.
270: 5944-5949
[Abstract]
[Full Text]
-
Barton, L. M., Gottgens, B., Gering, M., Gilbert, J. G. R., Grafham, D., Rogers, J., Bentley, D., Patient, R., Green, A. R.
(2001). From the Cover: Regulation of the stem cell leukemia (SCL) gene: A tale of two fishes. Proc. Natl. Acad. Sci. USA
98: 6747-6752
[Abstract]
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.